Inventor · disambiguated record
Indranil Nandi
Also filed as: NANDI INDRANIL
18 granted patents·37 pending applications·53 citations·filing 2002–2025
90Inventor score
Files withJUBILANT DRAXIMAGE INC13JUBILANT PHARMA HOLDINGS INC13JUBILANT GENERICS LTD11VERTICE PHARMA LLC3CLAYTON PHARMACEUTICALS LLC2
Top patents by PatentIndex Score
55 records- 0193US11020349B1Transmucosal dosage forms of remdesivirJUBILANT GENERICS LTD·Filed 2020·Granted Jun 1, 2021·5 cites·20 claims
- 0284USD851757SSyringeVERTICE PHARMA LLC·Filed 2018·Granted Jun 18, 2019·24 cites·1 claims
- 0379US11583521B2Long-acting injection dosage form of beta 3 adrenoreceptor agonistsJUBILANT PHARMA HOLDINGS INC·Filed 2021·Granted Feb 21, 2023·1 cites·13 claims
- 0478USD836772SSyringeVertice Pharma·Filed 2018·Granted Dec 25, 2018·19 cites·1 claims
- 0577US9989519B1Method for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension reference listed drug (RLD)CLAYTON PHARMACEUTICALS LLC·Filed 2017·Granted Jun 5, 2018·3 cites·23 claims
- 0676US11311518B1Parenteral dosage form of β3 adrenoreceptor agonistsJUBILANT PHARMA HOLDINGS INC·Filed 2021·Granted Apr 26, 2022·1 cites·14 claims
- 0772US12102789B1Radiopharmaceutical delivery system and use thereof for patient infusionJUBILANT DRAXIMAGE INC·Filed 2024·Granted Oct 1, 2024·0 cites·20 claims
- 0870US12226607B2Radiopharmaceutical delivery system and use thereof for patient infusionJUBILANT DRAXIMAGE INC·Filed 2024·Granted Feb 18, 2025·0 cites·20 claims
- 0966US12268547B2Imaging method for diagnosing cardiovascular diseaseJUBILANT DRAXIMAGE INC·Filed 2023·Granted Apr 8, 2025·0 cites·19 claims
- 1065US2025235175A1Imaging method for diagnosing cardiovascular diseaseJUBILANT DRAXIMAGE INC·Filed 2025·Application pending·0 cites
- 1161US2025144254A1Albumin conjugates and radiopharmaceutical composition thereofJUBILANT DRAXIMAGE INC·Filed 2024·Application pending·0 cites
- 1261US2025144256A1Albumin Conjugates and Process for Preparation thereofJUBILANT DRAXIMAGE INC·Filed 2024·Application pending·0 cites
- 1360US11013702B2Midodrine hydrochloride oral solution and uses thereofVERTICE PHARMA LLC·Filed 2018·Granted May 25, 2021·0 cites·16 claims
- 1460US2022370477A1Solid Oral Dosage Forms Of DexamethasoneJUBILANT GENERICS LTD·Filed 2022·Application pending·0 cites
- 1559US2022273670A1Modified release suspension of eslicarbazepineJUBILANT GENERICS LTD·Filed 2022·Application pending·0 cites
- 1658US2009186086A1Solid multilayer oral dosage formsPAR PHARMACEUTICAL INC·Filed 2008·Application pending·0 cites
- 1758US2022265552A1Eslicarbazepine suspensionJUBILANT GENERICS LTD·Filed 2022·Application pending·0 cites
- 1856US12417858B2Device to facilitate safe transport of medical radioisotope systemsJUBILANT DRAXIMAGE INC·Filed 2023·Granted Sep 16, 2025·0 cites·20 claims
- 1955US10889549B2Continuous process for the preparation of 2-(1H-imidazol-4-yl) ethanamine and pharmaceutically acceptable salts thereofJUBILANT GENERICS LTD·Filed 2020·Granted Jan 12, 2021·0 cites·20 claims
- 2055US2021322345A1Midodrine hydrochloride oral solution and uses thereofVERTICE PHARMA LLC·Filed 2021·Application pending·0 cites
- 2154US2022040196A1Pharmaceutical Composition of Chlordiazepoxide and Clidinium CombinationJUBILANT PHARMA HOLDINGS INC·Filed 2021·Application pending·0 cites
- 2254US2025104184A1Methods and techniques of resizing of scintigraphy imagesJUBILANT DRAXIMAGE INC·Filed 2024·Application pending·0 cites
- 2354US2022202698A1Extended release pharmaceutical compositions of riociguatJUBILANT PHARMA HOLDINGS INC·Filed 2021·Application pending·0 cites
- 2453US11318145B2Eslicarbazepine suspensionJUBILANT GENERICS LTD·Filed 2021·Granted May 3, 2022·0 cites·20 claims
- 2553US2022062213A1Methods and compositions of solabegron for reducing body fatJUBILANT PHARMA HOLDINGS INC·Filed 2021·Application pending·0 cites
- 2653US2021369619A1Transmucosal pharmaceutical compositions of antiviral drugsJUBILANT GENERICS LTD·Filed 2021·Application pending·0 cites
- 2753US2023012402A1Long-acting injection dosage form of beta 3 adrenoreceptor agonistsJUBILANT PHARMA HOLDINGS INC·Filed 2022·Application pending·0 cites
- 2853US2022062288A1Pharmaceutical compositions of vibegron for reducing body fatJUBILANT PHARMA HOLDINGS INC·Filed 2021·Application pending·0 cites
- 2953US2023093338A1Radiopharmaceutical generation and infusion systemsJUBILANT PHARMA HOLDINGS INC·Filed 2021·Application pending·0 cites
- 3052US2021236628A1Self-emulsifying solid oral dosage forms of allergen and their preparation thereofJUBILANT GENERICS LTD·Filed 2021·Application pending·0 cites
- 3152US2021275546A1High drug load solid oral dosage forms of dexamethasoneJUBILANT PHARMA HOLDINGS INC·Filed 2021·Application pending·0 cites
- 3251US2006193915A1Compression coated tabletsGUO MINTONG·Filed 2006·Application pending·0 cites
- 3351US2005181043A1Alendronate salt tablet compositionsFiled 2004·Application pending·0 cites
- 3450US11642351B2Eslicarbazepine suspensionJUBILANT GENERICS LTD·Filed 2020·Granted May 9, 2023·0 cites·19 claims
- 3550US2021236629A1Self-emulsifying dosage forms of allergen and their preparation thereofJUBILANT PHARMA HOLDINGS INC·Filed 2021·Application pending·0 cites
- 3650US2024193767A1Method for obtaining arterial input function from region of interestJUBILANT DRAXIMAGE INC·Filed 2024·Application pending·0 cites
- 3749US11331324B2Modified release suspension of eslicarbazepineJUBILANT GENERICS LTD·Filed 2020·Granted May 17, 2022·0 cites·19 claims
- 3849US2023084536A1Pharmaceutical compositions for imaging, diagnosis and treatment of cancerJubilant Radiopharma·Filed 2022·Application pending·0 cites
- 3949US2021353546A1Dual release pharmaceutical compositions comprising the combination of a beta-3 adrenoreceptor agonist and a muscarinic receptor antagonistJUBILANT PHARMA HOLDINGS INC·Filed 2021·Application pending·0 cites
- 4049US2021148893A1Method for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension reference listed drug (rld)CLAYTON PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 4149US2023000837A1Parenteral dosage form of beta 3 adrenoreceptor agonistsJUBILANT PHARMA HOLDINGS INC·Filed 2022·Application pending·0 cites
- 4246US2024249856A1Systems for radioisotope generation and methods of preparation and administrationJUBILANT DRAXIMAGE INC·Filed 2023·Application pending·0 cites
- 4346US2004068000A1Compression coated tabletsFiled 2002·Application pending·0 cites
- 4445US11327065B1Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereofJUBILANT GENERICS LTD·Filed 2021·Granted May 10, 2022·0 cites·20 claims
- 4545US2005008704A1Pharmaceutical composition for solubility enhancement of hydrophobic drugsFiled 2003·Application pending·0 cites
- 4645US2024010675A1Preparation of highly concentrated allergenic intermediateJubilant HollisterStier LLC·Filed 2021·Application pending·0 cites
- 4745US2005181052A1Lansoprazole microtabletsFiled 2004·Application pending·0 cites
- 4845US2025145664A1Pharmaceutical compositions for imaging, diagnosis and treatment of cancerJUBILANT DRAXIMAGE INC·Filed 2025·Application pending·0 cites
- 4943US2023046186A1Process for the preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereofJUBILANT PHARMA HOLDINGS INC·Filed 2022·Application pending·0 cites
- 5041US12390579B2Radiopharmaceutical delivery system for patient infusionJUBILANT DRAXIMAGE INC·Filed 2025·Granted Aug 19, 2025·0 cites·20 claims
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Indranil Nandi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →